PUR-WASH- water solution 
Niagara Pharmaceuticals Inc.

----------

Pur-Wash



Purified Water, 98.3%



Ophthalmic Solution



Eyewash

Drug Facts

Active ingredient

Purified water 98.3%

Purpose

Eyewash

Use

For cleansing the eye to help relieve irritation or burning by removing loose foreign material

Warnings

For external use only

Do not use

  • if you experience any open wounds in or near the eyes and obtain immediate medical treatment
  • if solution changes color or becomes cloudy

When using this product

  • to avoid contamination, do not touch tip of container to any surface
  • do not reuse
  • once opened, discard

Stop use and ask a doctor if

  • side effects occur. You may report side effects to FDA at 1-800-FDA-1088
  • changes in vision
  • eye pain
  • condition worsens or persists
  • continued redness or irritation of the eye

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

boric acid, sodium borate, sodium chloride

Questions ?

☎ Call 973-568-3361 9 a.m. to 5 p.m. EST Mon-Fri

Manufactured by:

Niagara Pharmaceuticals Inc.

60 Innovation Dr.

Dundas ON L9H 7P3

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Label

Pur-Wash

Purified Water, 98.3%

Ophthalmic Solution

Eyewash

Single Use

Manufactured by:

Niagara Pharmaceuticals Inc.

60 Innovation Dr.

Dundas ON L9H 7P3

Made in Canada

Sterile Solution

4 Fl Oz [118 mL]

PDP-Drug Facts

PUR-WASH 
water solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65785-169
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER929 g  in 946 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:65785-169-0130 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/12/2011
2NDC:65785-169-04118 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/12/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02230509/12/2011
Labeler - Niagara Pharmaceuticals Inc. (205477792)
Establishment
NameAddressID/FEIBusiness Operations
Niagara Pharmaceuticals Inc.205477792manufacture(65785-169)

Revised: 3/2021
Document Id: bed9635f-79f8-9503-e053-2a95a90a013e
Set id: beda35c3-9a8b-47ad-e053-2995a90a7b1b
Version: 1
Effective Time: 20210331
 
Niagara Pharmaceuticals Inc.